Bernard C (1856) Lectures on experimental physiology, delivered at the college De France, Paris, during the year 1855. Northwest Med Surg J 5(5):218–231

PubMed  PubMed Central  Google Scholar 

Bearn AG, Billing BH, Sherlock S (1951) Hepatic glucose output and hepatic insulin sensitivity in diabetes mellitus. Lancet 2(6686):698–701. https://doi.org/10.1016/s0140-6736(51)91476-6

Article  CAS  PubMed  Google Scholar 

Mitrakou A, Kelley D, Mokan M et al (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326(1):22–29. https://doi.org/10.1056/NEJM199201023260104

Article  CAS  PubMed  Google Scholar 

Yki-Jarvinen H (1993) Action of insulin on glucose metabolism in vivo. Bailliere’s Clin Endocrinol Metab 7(4):903–927. https://doi.org/10.1016/s0950-351x(05)80239-3

Article  CAS  Google Scholar 

Adiels M, Westerbacka J, Soro-Paavonen A et al (2007) Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 50(11):2356–2365. https://doi.org/10.1007/s00125-007-0790-1

Article  CAS  PubMed  Google Scholar 

Seppala-Lindroos A, Vehkavaara S, Hakkinen AM et al (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87(7):3023–3028. https://doi.org/10.1210/jcem.87.7.8638

Article  CAS  PubMed  Google Scholar 

Adiels M, Taskinen MR, Packard C et al (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49(4):755–765. https://doi.org/10.1007/s00125-005-0125-z

Article  CAS  PubMed  Google Scholar 

Yki-Jarvinen H (2014) Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2(11):901–910. https://doi.org/10.1016/S2213-8587(14)70032-4

Article  CAS  PubMed  Google Scholar 

Yki-Jarvinen H, Luukkonen PK, Hodson L, Moore JB (2021) Dietary carbohydrates and fats in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 18(11):770–786. https://doi.org/10.1038/s41575-021-00472-y

Article  CAS  PubMed  Google Scholar 

Pais R, Charlotte F, Fedchuk L et al (2013) A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol 59(3):550–556. https://doi.org/10.1016/j.jhep.2013.04.027

Article  CAS  PubMed  Google Scholar 

Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS (2023) Global burden of liver disease: 2023 update. J Hepatol 79(2):516–537. https://doi.org/10.1016/j.jhep.2023.03.017

Article  PubMed  Google Scholar 

Rinella ME, Lazarus JV, Ratziu V et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79(6):1542–1556. https://doi.org/10.1016/j.jhep.2023.06.003

Article  CAS  PubMed  Google Scholar 

Anstee QM, Targher G, Day CP (2013) Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10(6):330–344. https://doi.org/10.1038/nrgastro.2013.41

Article  CAS  PubMed  Google Scholar 

Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115(5):1343–1351. https://doi.org/10.1172/JCI23621

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luukkonen PK, Qadri S, Ahlholm N et al (2022) Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. J Hepatol 76(3):526–535. https://doi.org/10.1016/j.jhep.2021.10.013

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith GI, Shankaran M, Yoshino M et al (2020) Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. J Clin Invest 130(3):1453–1460. https://doi.org/10.1172/JCI134165

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brunt EM (2010) Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7(4):195–203. https://doi.org/10.1038/nrgastro.2010.21

Article  PubMed  Google Scholar 

Chaurasia B, Summers SA (2021) Ceramides in metabolism: key lipotoxic players. Annu Rev Physiol 83:303–330. https://doi.org/10.1146/annurev-physiol-031620-093815

Article  CAS  PubMed  Google Scholar 

Luukkonen PK, Zhou Y, Sadevirta S et al (2016) Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol 64(5):1167–1175. https://doi.org/10.1016/j.jhep.2016.01.002

Article  CAS  PubMed  Google Scholar 

Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R (2015) Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 13(4):643–654. https://doi.org/10.1016/j.cgh.2014.04.014. (e641-649; quiz e639-640)

Article  PubMed  Google Scholar 

Jamialahmadi O, Mancina RM, Ciociola E et al (2021) Exome-wide association study on alanine aminotransferase identifies sequence variants in the GPAM and APOE associated with fatty liver disease. Gastroenterology 160(5):1634-1646 e1637. https://doi.org/10.1053/j.gastro.2020.12.023

Article  CAS  PubMed  Google Scholar 

Xia M, Ma S, Huang Q et al (2022) NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the Shanghai Changfeng Study. Aliment Pharmacol Ther 55(6):705–721. https://doi.org/10.1111/apt.16772

Article  CAS  PubMed  Google Scholar 

Luukkonen PK, Qadri S, Lehtimaki TE et al (2021) The PNPLA3-I148M variant confers an antiatherogenic lipid profile in insulin-resistant patients. J Clin Endocrinol Metab 106(1):e300–e315. https://doi.org/10.1210/clinem/dgaa729

Article  PubMed  Google Scholar 

Kubiliun MJ, Cohen JC, Hobbs HH, Kozlitina J (2022) Contribution of a genetic risk score to ethnic differences in fatty liver disease. Liver Int 42(10):2227–2236. https://doi.org/10.1111/liv.15322

Article  PubMed  PubMed Central  Google Scholar 

Tamaki N, Ahlholm N, Luukkonen PK et al (2022) Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease. J Clin Invest 132(21):e162513. https://doi.org/10.1172/JCI162513

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chalasani N, Younossi Z, Lavine JE et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1):328–357. https://doi.org/10.1002/hep.29367

Article  PubMed  Google Scholar 

Eslam M, Newsome PN, Sarin SK et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73(1):202–209. https://doi.org/10.1016/j.jhep.2020.03.039

Article  PubMed  Google Scholar 

Hagstrom H, Vessby J, Ekstedt M, Shang Y (2023) 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical. J Hepatol. https://doi.org/10.1016/j.jhep.2023.08.026

Article  PubMed  Google Scholar 

National Center for Health Statistics. In, Health, United States, 2019: Data table for Figure 11. Hyattsville, MD. 2019. Available from: https://www.cdc.gov/nchs/hus/data-finder.htm. Accessed 21 Nov 2023

Carroll M, Kit B, Lacher D (2015) Trends in elevated triglyceride in adults: United States, 2001-2012. NCHS Data Brief (198):198

Qadri S, Vartiainen E, Lahelma M et al (2024) Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: a meta-analysis. JHEP Rep 6(1):100928. https://doi.org/10.1016/j.jhepr.2023.100928

Article  PubMed  Google Scholar 

Ajmera V, Cepin S, Tesfai K et al (2023) A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol 78(3):471–478. https://doi.org/10.1016/j.jhep.2022.11.010

Article  CAS  PubMed  Google Scholar 

Younossi ZM, Golabi P, de Avila L et al (2019) The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 71(4):793–801. https://doi.org/10.1016/j.jhep.2019.06.021

Article  PubMed  Google Scholar 

Zaharia OP, Strassburger K, Strom A et al (2019) Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol 7(9):684–694. https://doi.org/10.1016/S2213-8587(19)30187-1

Article  PubMed  Google Scholar 

Asero C, Giandalia A, Cacciola I et al (2023) High prevalence of severe hepatic fibrosis in type 2 diabetic outpatients screened for non-alcoholic fatty liver disease. J Clin Med 12(8):2858. https://doi.org/10.3390/jcm12082858

Article  CAS  PubMed  PubMed Central  Google Scholar